doi: 10.1056/NEJM197505082921906.
Prevention of Rh hemolytic disease--ten years' clinical experience with Rh immune globulin
- PMID: 804134
- DOI: 10.1056/NEJM197505082921906
Item in Clipboard
Prevention of Rh hemolytic disease--ten years' clinical experience with Rh immune globulin
N Engl J Med.
.
Abstract
PIP: 10 years' clinical experience with Rh immune globulin in the prevention of Rh hemolytic disease is reported. The data show a steady decline in the actual numbers of sensitized mothers and affected babies for each successive year after the initiation of treatment with Rh immune globulin. It is concluded that all Rh-negative women who are at any risk of becoming sensitized to Rh must be protected with Rh immune globulin irrespective of whether they have had a term pregnancy (Rh-positive infant), an abortion or an accidental transfusion with Rh-positive blood.
Similar articles
-
[Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].Rev Chil Obstet Ginecol. 1981;46(4):206-14. Rev Chil Obstet Ginecol. 1981. PMID: 6099901 Spanish. No abstract available.
-
Rh hemolytic disease of the newborn: its cause and prevention.Prog Clin Biol Res. 1981;70:185-302. Prog Clin Biol Res. 1981. PMID: 6273932 Review. No abstract available.
-
Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.Prog Clin Biol Res. 1981;70:213-7. Prog Clin Biol Res. 1981. PMID: 6273934 No abstract available.
-
Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.Arch Med Res. 1996 Autumn;27(3):373-6. Arch Med Res. 1996. PMID: 8854398
-
[Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].Akush Ginekol (Sofiia). 1986;25(3):84-90. Akush Ginekol (Sofiia). 1986. PMID: 3019168 Review. Bulgarian. No abstract available.
Cited by
-
Exchange transfusion for hemolytic hyperbilirubinemia: could some be averted by emergent administration of an inhibitor of bilirubin production?J Perinatol. 2021 Apr;41(4):860-864. doi: 10.1038/s41372-020-0736-8. Epub 2020 Jul 15. J Perinatol. 2021. PMID: 32669646
-
Point-of-care determination of the frequency of Rhesus(D)-negative blood types and the uptake of anti(D) immunoglobulin among Rh(D)-negative women in Dadu district, Sindh, Pakistan.PLOS Glob Public Health. 2025 Apr 9;5(4):e0004395. doi: 10.1371/journal.pgph.0004395. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 40203017 Free PMC article.
-
Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease.Front Immunol. 2020 Nov 13;11:531543. doi: 10.3389/fimmu.2020.531543. eCollection 2020. Front Immunol. 2020. PMID: 33281808 Free PMC article. Review.
-
Alloimmune hemolytic disease of the fetus and newborn: genetics, structure, and function of the commonly involved erythrocyte antigens.J Perinatol. 2023 Dec;43(12):1459-1467. doi: 10.1038/s41372-023-01785-3. Epub 2023 Oct 17. J Perinatol. 2023. PMID: 37848604 Review.
-
Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.AJOG Glob Rep. 2023 Mar 24;3(2):100203. doi: 10.1016/j.xagr.2023.100203. eCollection 2023 May. AJOG Glob Rep. 2023. PMID: 37229151 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
